Proportions of patients with specific plasma cell disorder. By adding additional variables like GEP, serum immunoglobulin FLC, and perhaps other variables like MRI and M-protein size, and bone marrow plasmacytosis, the transitional category of SMM may shrink, allowing for more refined definitions of premalignant (MGUS) and malignant (active MM) plasma cell disorders.